Brief: Epirus Biopharmaceuticals entered into share purchase agreement with Taro Pharmaceuticals
Oct 7 (Reuters) - EPIRUS Biopharmaceuticals Inc EPRS.O : * Says on October 1, co entered into and closed a share purchase agreement with taro pharmaceuticals inc * Says agreement for sale by co to taro of all shares of zalicus pharmaceuticals ltd, co's Canadian unit * Received from taro payment of C$ $5 million in cash and promissory note of C$ 5 million with maturity date of July 1, 2017 * Source text (http://1.usa.gov/1JTheSI) * Further company coverage EPRS.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Epirus Biopharmaceuticals
See all newsBrief: Epirus Biopharmaceuticals entered settlement satisfaction amendment with Livzon Mabpharm
Brief: Jennison Associates dissolves passive stake in Epirus Biopharmaceuticals
Brief: Epirus Biopharmaceuticals enters term sheet with Zaklady Farmaceutyczne
Brief: Epirus Biopharmaceuticals announces reprioritization of pipeline
Brief: Epirus biopharmaceuticals files for non-timely 10-k - sec filing